Chlamydia pneumoniae

The Lung and the Heart

Häftad, Engelska, 1999

729 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Chlamydia pneumoniae is now recognized as an important human pathogen. Chlamydia pneumoniae is involved in 5%-15% of community acquired pneumonias, and recent data indicate its relevance in severe pneumonia and as a respiratory pathogen in immunocompromised subjects.

Produktinformation

Utgivningsdatum1999-01-01
Mått155 x 235 x 12 mm
Vikt335 g
FormatHäftad
SpråkEngelska
Antal sidor205
Upplaga1999
FörlagSpringer Verlag
ISBN9788847000476

Tillhör följande kategorier

Lungmedicin inom Medicin

History of Chlamydia pneumoniae (TWAR).- Chlamydia pneumoniae: Culture Methods.- Serology for Chlamydia pneumoniae (TWAR).- Chlamydia pneumoniae: Molecular Biology Methods.- Chlamydia pneumoniae Infections: Applications of Laboratory Methods.- Chlamydia pneumoniae: How to Document Respiratory Infection.- Chlamydia pneumoniae: Epidemiology.- Pharmacological and Pharmacokinetic Basis of Chlamydia pneumoniae Treatment.- Chlamydia pneumoniae: Clinical Characteristics of Acute Respiratory Infections.- Are Atypical Pathogens Important for Patients with Community-Acquired Pneumonia?.- Immunology of Chlamydia pneumoniae.- Chronic Chlamydia pneumoniae Infections.- Chlamydia pneumoniae: A New Possible Cause of Asthma.- Chlamydia pneumoniae: An Important Pathogen in Chronic Bronchitis.- Chlamydia pneumoniae: A New Threat for HIV-infected Subjects.- Chlamydia pneumoniae: Epidemiology of a New Cardiovascular Risk Factor.- Chlamydia pneumoniae and Atherosclerosis: Mechanisms of Vascular Damage.- Chlamydia pneumoniae and Atherosclerosis: Animal Models.- Open and Controlled Intervention Trials for “Unusual” Anti-Chlamydia pneumoniae Indications: Asthma, Atherosclerosis, Myocardial Infarction.- Clarithromycin Treatment of Helicobacter pylori and Chlamydia pneumoniae Infections Decreases Fibrinogen Plasma Level in Patients with Ischemic Heart Disease.- Antibiotic Treatment in Atherosclerosis and Myocardial Infarction.- A Controlled Intervention Study with Antibiotics in Symptomatic Coronary Patients Irrespective of Serology.- Open-Label Before-After Trials of Anti-Chlamydia pneumoniae Antibiotics in Asthma.- Treatment of Chronic Infection with Chlamydia pneumoniae in Asthma.- Chlamydia pneumoniae Infections in Children.- Perspectives and Perceptions on the Clinical Relevance ofChlamydia pneumoniae Infection.